Form 4: Abdiel Capital Entities Report Significant Sales of Appian Corp. Stock Under Pre-Arranged Trading Plan
Insider Trading Report
Abdiel Capital Advisors, LP and affiliated entities, a 10% owner of Appian Corp., reported the sale of 576,950 shares of Class A Common Stock over three days in June 2025, pursuant to a Rule 10b5-1 trading plan.
Summary
- Abdiel Capital Advisors, LP, along with its affiliated entities Abdiel Qualified Master Fund, LP, Abdiel Capital, LP, and Abdiel Partners, LLC, reported the sale of a total of 576,950 shares of Appian Corp. (APPN) Class A Common Stock.
- The sales occurred over three consecutive trading days in June 2025: 125,615 shares on June 4, 2025; 225,615 shares on June 5, 2025; and 225,720 shares on June 6, 2025.
- The shares were sold at weighted average prices ranging from approximately $31.80 to $32.30 per share, with specific transaction prices varying within ranges for each day's sales (e.g., $31.56 to $32.09 on June 4, 2025; $31.65 to $32.00 and $32.00 to $32.72 on June 5, 2025; $31.93 to $32.45 on June 6, 2025).
- Following these transactions, the aggregated beneficial ownership of Appian Corp. Class A Common Stock by the Abdiel entities stands at 7,853,441 shares.
- These transactions were conducted under a Rule 10b5-1(c) pre-arranged trading plan, indicating they were scheduled in advance.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly negative. While significant insider selling can be a negative signal, the fact that it's under a Rule 10b5-1 plan mitigates the negative interpretation, as it implies the sales were pre-planned and not based on new, adverse information.
Positives
- The transactions were executed under a Rule 10b5-1(c) trading plan, which suggests the sales were pre-scheduled and not necessarily indicative of new negative sentiment regarding Appian Corp.'s immediate prospects or a reaction to recent non-public information.
Negatives
- A significant sale of 576,950 shares by a 10% owner and director group could be perceived negatively by the market, as it reduces insider ownership.
- The sales occurred at prices ranging from $31.56 to $32.72, which might be seen as the reporting persons taking profits or rebalancing their portfolio.
Risks
- While executed under a 10b5-1 plan, large insider sales can sometimes lead to negative market sentiment or speculation about the company's future performance, potentially impacting share price.
Future Outlook
The document does not provide any forward-looking statements or guidance regarding Appian Corp.'s business operations or financial performance. It solely reports past (or future, given the dates) insider trading activity.
Industry Context
This Form 4 filing is specific to insider trading activity at Appian Corp. and does not provide broader industry context or trends. Insider sales are a common occurrence across all industries, often for diversification or liquidity purposes, especially when executed under pre-arranged 10b5-1 plans.
Related Party Transactions
- The reported sales are related party transactions as they involve Abdiel Capital Advisors, LP and its affiliated entities, which are identified as a 10% owner and potentially a director of Appian Corp. through Colin T. Moran.
Stakeholder Impact
- Shareholders may interpret the significant insider selling as a potential lack of confidence, although the 10b5-1 plan mitigates this concern. This could lead to short-term price volatility.
- The company's reputation might be marginally affected if the market misinterprets the sales as a lack of confidence, despite the 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 06/04/2025 | First day of reported Class A Common Stock sales by Abdiel Capital entities. |
| 06/05/2025 | Second day of reported Class A Common Stock sales by Abdiel Capital entities. |
| 06/06/2025 | Third and final day of reported Class A Common Stock sales by Abdiel Capital entities; also the filing date of the Form 4. |
Recommendation
holdKeywords
Appian Corp, APPN, SEC Form 4, Insider Trading, Beneficial Ownership, Stock Sale, Abdiel Capital, 10b5-1 Plan, Institutional Investor, Equity Sales
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.